Argenx
ARGX
#579
Rank
HK$278.60 B
Marketcap
HK$4,621
Share price
0.85%
Change (1 day)
20.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : HK$37.31 Billion

According to Argenx 's latest financial reports the company's total assets are HK$37.31 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31HK$24.48 B10.18%
2021-12-31HK$22.22 B2.26%
2020-12-31HK$21.73 B54.71%
2019-12-31HK$14.04 B136.99%
2018-12-31HK$5.92 B42.11%
2017-12-31HK$4.17 B359.74%
2016-12-31HK$0.90 B113.07%
2015-12-31HK$0.42 B-36.55%
2014-12-31HK$0.67 B81.46%
2013-12-31HK$0.36 B57.33%
2012-12-31HK$0.23 B-27.03%
2011-12-31HK$0.32 B153.84%
2010-12-31HK$0.12 B